23876-18-8 Usage
General Description
2-(2-Methyl-6-nitrophenyl)acetic acid is a unique chemical compound with the molecular formula C9H9NO4. 2-(2-Methyl-6-nitrophenyl)acetic acid belongs to the family of benzoic acids and derivatives with benzoic acid being a compound comprising a benzene ring core carrying a carboxylic acid substituent. Specifically, it consists of a 2-methyl-6-nitrophenyl group attached to an acetic acid moiety. The nitro group and the methyl group are both electron-attracting groups causing a drop in electron density in the attached benzene ring. The characteristics and properties of this compound depend, among other things, on the presence of these specific chemical groups. The compound is usually utilized for various scientific and laboratory applications.
Check Digit Verification of cas no
The CAS Registry Mumber 23876-18-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,8,7 and 6 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 23876-18:
(7*2)+(6*3)+(5*8)+(4*7)+(3*6)+(2*1)+(1*8)=128
128 % 10 = 8
So 23876-18-8 is a valid CAS Registry Number.
23876-18-8Relevant articles and documents
FORMULATIONS FOR PHARMACEUTICAL AGENTS IONIZABLE AS FREE ACIDS OR FREE BASES
-
Page/Page column 168; 217, (2008/06/13)
-
Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
-
, (2008/06/13)
The present invention relates to pyrrole substituted 2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
Combination therapy for the treatment of cancer
-
, (2008/06/13)
The present invention relates to methods for treatment or prevention of neoplasia disorders using protein tyrosine kinase inhibitors in combination with cyclooxygenase inhibitors, in particular cyclooxygenase-2 selective inhibitors.